enVVeno Medical Corporation

About enVVeno Medical Corporation

enVVeno Medical Corporation is dedicated to setting new standards for venous care, focusing on innovative solutions for Chronic Venous Insufficiency (CVI) and related conditions in the deep veins of the leg.

Products & Services

VenoValve:A first-in-class surgical replacement venous valve for the treatment of Chronic Venous Insufficiency (CVI) in the deep veins of the leg. Currently investigational and not approved for market use.

enVVe:An investigational medical device in development for venous care, with details available from patient experiences in the SAVVE Pivotal Trial. Not yet approved for market use.

Specialties

Venous Care Chronic Venous Insufficiency (CVI) Treatment Surgical Replacement Venous Valves

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 15000000 MR: - FA: $15.0 million FAN: 15000000	D: 2024-09-26 FD: 2024-09-26	2 investors
2	RT: Private Placement T: - FT: Private Placement	A: 28000000 MR: - FA: approximately $28 million FAN: 28000000	D: 2023-10-06 FD: 2023-10-06	6 investors

Public Offering Latest

2024-09-26

$15.0M

2 investors (Pro only)

Private Placement 2023-10-06

$28.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Robert Berman

Chief Executive Officer, Director

F

Francis Duhay

Director

R

Robert Gray

Director

M

Matthew Jenusaitis

Director

S

Sanjay Shrivastava

Director

M

Marc H. Glickman

Senior Vice President and Chief Medical Officer

View 8 more team members with Pro

Unlock Full Team Directory

Recent News